SCHEMBL24820591

SCHEMBL24820591

COC(=O)c1cc(F)ccc1-c1cc(Cl)nc(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.49
SLC6A4 P31645 3/20 0.49
SLC6A3 Q01959 3/20 0.49
SMN1; SMN2 Q16637 4/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
PLA2G2A P14555 4/20 0.46
CYP46A1 Q9Y6A2 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
ALPL P05186 1/20 0.45
ALDH1A1 P00352 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
ROCK2 O75116 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30792152 1.00 KDM4E (0.49) KDM4ESLC6A4SLC6A3SMN1; SMN2NPC1
SCHEMBL31233391 0.88 MAPT (0.43) KDM4ESLC6A4SLC6A3SMN1; SMN2NPC1
SCHEMBL29189961 0.85 TSHR (0.52) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL30825433 0.84 CA12 (0.53) KDM4ESLC6A4SLC6A3SMN1; SMN2NPC1
SCHEMBL30792061 0.82 EIF4E (0.48) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL24820600 0.82 EIF4E (0.48) KDM4EALDH1A1HPGDHSD17B10
SCHEMBL24820313 0.81 SLC6A3 (0.65) KDM4ESLC6A4SLC6A3SMN1; SMN2NPC1
SCHEMBL24820593 0.81 GRM2 (0.45) ROCK1CASP1
SCHEMBL24820114 0.80 KDM4E (0.43) KDM4ESLC6A4SLC6A3SMN1; SMN2NPC1
SCHEMBL5120807 0.79 SLC6A3 (0.67) KDM4ESLC6A4SLC6A3SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4637749-A2 CBL-B MODULATORS AND USES THEREOF Nimbus Clio, Inc. (US) 2025-10-29 EP disclosed
WO-2024137674-A2 CBL-B MODULATORS AND USES THEREOF NIMBUS CLIO, INC. (US) 2024-06-27 WO disclosed
WO-2024086730-A1 HETEROCYCLIC CBL-B INHIBITORS FOR THE TREATMENT OF CANCER HOTSPOT THERAPEUTICS, INC. (US) 2024-04-25 WO disclosed
WO-2022272248-A1 CBL-B MODULATORS AND USES THEREOF NIMBUS CLIO, INC. (US) 2022-12-29 WO disclosed